Fragment, CJC-1295 (No DAC), Ipamorelin 12mg (Blend)

$85.00

hGH Fragment plus CJC-1295 (No DAC) plus Ipamorelin 12mg Blend is the three-active lyophilised vial combining the 16aa lipolytic GH fragment with the GHRH analogue CJC-1295 and the selective ghrelin pentapeptide Ipamorelin. Each active greater than 99 percent HPLC verified.

Category:

Peptide Science research editorial team.

hGH Fragment plus CJC-1295 (No DAC) plus Ipamorelin 12mg Blend Overview

hGH Fragment plus CJC-1295 (No DAC) plus Ipamorelin 12mg Blend from Peptide Science is the three-active lyophilised vial combining the 16-amino-acid C-terminal lipolytic fragment of human growth hormone with the modified GHRH analogue CJC-1295 No DAC and the selective ghrelin pentapeptide Ipamorelin. The combination supports preclinical research that studies lipolytic-pathway and GH-secretagogue effects in one experimental arm.

Combined Three-Pathway Background

The three-active combination pairs upstream GH-axis stimulation (CJC-1295 plus Ipamorelin acting at the pituitary GHRH and GHS-R1a receptors respectively) with downstream lipolytic-pathway activation (hGH Fragment 176-191 acting at adipocyte beta-3-adrenergic-receptor-adjacent pathways without GH-receptor signalling). The structural rationale separates the somatotropic from the lipolytic effects of native hGH while providing both pathway signals in a single research vial. Browse the broader growth-hormone peptide range.

Vial Specifications

hGH Fragment plus CJC-1295 (No DAC) plus Ipamorelin 12mg Blend research specifications
Property Value
Active 1 hGH Fragment 176-191, 16aa lipolytic C-terminal fragment of human growth hormone
Active 2 CJC-1295 (No DAC), 30aa modified GHRH analogue
Active 3 Ipamorelin, 5aa selective ghrelin-receptor agonist pentapeptide
Combined strength 12 mg total per vial
Supplied form Lyophilised powder, sealed vial
Purity each active greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

Reconstitution and Handling

The three-active vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. For the parent secretagogue pairing without the lipolytic fragment, see CJC-1295 No DAC plus Ipamorelin 10mg Blend. For the single-compound lipolytic fragment, see hGH Fragment 176-191 6mg.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent for each active, with mass-spectrometry confirmation of all three compounds. A Certificate of Analysis accompanies every order listing each active and its measured purity. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.

Reviews

There are no reviews yet.

Be the first to review “Fragment, CJC-1295 (No DAC), Ipamorelin 12mg (Blend)”

Your email address will not be published. Required fields are marked *

Scroll to Top